Selegiline

PLURIMEN 5 mg COMPRIMIDOS

5 mg comprimidoSpainMarketedAuthorised 31 Dec 1988

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Selegiline

PLURIMEN 5 mg COMPRIMIDOS

5 mg comprimidoSpainMarketedAuthorised 31 Dec 1988

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Selegiline Hydrochloride

United States · 5MG, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · G and W Labs INC

ZelaparUnited States · 1.25MG · tablet, orally disintegrating · Bausch

Cloridrato de SelegilinaBrazil · Apotex do Brasil Ltda

Cloridrato de SelegilinaBrazil · Biosintética Farmacêutica Ltda

DeprilanBrazil · Biosintética Farmacêutica Ltda

SelegosRomania · 5mg · compr. · Medochemie LTD.

Parkryl Tablets "M.S."(Selegiline)Taiwan · 錠劑 · 美時化學製藥股份有限公司

EmsamUnited States · 12MG/24HR, 6MG/24HR, 9MG/24HR · film, extended release · Somerset

Packs

Pack	Code	Status
PLURIMEN 5 mg COMPRIMIDOS , 20 comprimidos	663306
PLURIMEN 5 mg COMPRIMIDOS , 50 comprimidos	663307

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Selegiline
Strength: 5 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Dec 1988
Registration: 58113
Marketing authorisation holder: Orion Corporation
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración